Position in ANIK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,585,314
+$253,272 QoQ
Shares Held
245,066
+6.6% QoQ
Ownership
1.83%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. ANIK ranks #26 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in ANIK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,585,314 | 245,066 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,332,042 | 229,796 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,863,578 | 297,979 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,647,960 | 175,315 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,312,755 | 124,079 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,521,431 | 167,760 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,530,955 | 153,764 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,805,306 | 154,061 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,873,539 | 152,923 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,898,620 | 153,489 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,835,069 | 169,244 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,578,170 | 192,065 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,732,728 | 143,677 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,971,028 | 138,267 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,310,529 | 145,626 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,618,266 | 152,028 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,302,403 | 192,760 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,278,467 | 170,389 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,792,815 | 161,675 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,570,657 | 177,882 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,347,004 | 192,816 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,846,894 | 192,373 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,101,067 | 156,895 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,925,312 | 167,429 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,691,264 | 177,346 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,859,042 | 237,255 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||